Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders ...

Summary by Enid News & Eagle
Melbourne, Australia, June 22, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX | OTCQB:INNMF), (“Amplia” or the “Company”) provides a letter to shareholders from CEO and Managing Director Dr. Chris Burns outlining the potential for the Company’s best-in-class FAK inhibitor…

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders ...

Melbourne, Australia, June 22, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX | OTCQB:INNMF), (“Amplia” or the “Company”) provides a letter to shareholders from CEO and Managing Director Dr. Chris Burns outlining the potential for the Company’s best-in-class FAK inhibitor…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news on Monday, June 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Melbourne, Australia icon

Melbourne, Australia

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal